Comment on Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis.

Comment on Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis. Curr Vasc Pharmacol. 2019;17(4):350-351 Authors: Albert V, Arnet I, Gudka S Abstract PMID: 31218946 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31218946?dopt=Abstract

Source: Current Vascular Pharmacology - June 21, 2019 Category: Drugs & Pharmacology Authors: Albert V, Arnet I, Gudka S Tags: Curr Vasc Pharmacol Source Type: research

More News: Atrial Fibrillation | Bleeding | Drugs & Pharmacology